Replies to post #133585 on NanoViricides Inc. (NNVC)

[arvitar]

“Every single large pharma has expressed an interest in our technology but they all want to wait until we're in humans next year before proposing a licensing deal.” Eugene Seymour, August 2013

http://www.biopharma-reporter.com/Upstream-Processing/NanoViricides-Builds-Plant-to-Prep-for-Viral-Penicillin-Pipeline

And yet, here is NNVC four years later, waiting for Moffat to repeat some skin patch studies in a biologically irrelevant model of shingles.

From "human trials next year", with every single large pharma in the world wanting a piece in 2013, to running out of cash in 2018 without having gotten IND approval for a single candidate.

Quite the contrast between what Seymour says when he flaps his gums and the actual outcome.